CAS: 497-26-7; 2-Methyl-1,3-Dioxolane

该化合物是一种循环烷,通常用作有机合成的溶剂和中间剂. 它的高度稳定性,低毒性和有利的沸点(92-94°C)使它适合用于制药,农用化学品和特殊化学品. 化合物的循环结构增强了其对水解的抗药性,确保了需要无水条件的反应的可靠性. 由于其选择性反应性,它也被用作碳基化合物的保护群体. 此外,它与水和有机溶剂的不易性提高了配制的灵活性. 产品因其在工业和实验室环境中的纯度和一贯性能而受到重视.

结构式图片

相似化合物

5694-68-8 4360-63-8 18742-02-4

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号201230-82-2 carbon monoxide | CAS号111-46-6 二乙二醇 | CAS号107-21-1 乙二醇 | CAS号75-07-0 乙醛 | CAS号123-63-7 三聚乙醛 | CAS号74-86-2 乙炔 | CAS号75-21-8 环氧乙烷 | CAS号110-80-5 乙二醇乙醚 | CAS号108-05-4 乙酸乙烯酯 | CAS号546-67-8 四乙酸铅 | CAS号33528-35-7 己烷2,5-二酮单乙烯缩酮 | CAS号542-59-6 乙酸-2-羟基乙酯 | CAS号542-58-5 2-氯乙酸乙酯 | CAS号141-78-6 乙酸乙酯 | CAS号13623-91-1 2-methyl-1,3-di... | CAS号105148-92-3 3,7-dichlorotri... | CAS号4360-63-8 2-溴甲基-1,3-二氧戊烷 | CAS号55091-64-0 1-methyl-1-phen... | CAS号107-21-1 乙二醇

合成工艺路线路线简述

  • 合成目标产物 2-Methyl-1,3-Dioxolane 主要起始原料 Ethanol And Ethylene Glycol
  • (文献来源)合成步骤主要原料 Ethanol 和 Ethylene Glycol
2-乙烯氧基乙醇置于acidic Catalyst体系中,化学反应生成 2-甲基-1,3-二氧戊环
参考文献:有序降解:两种大分子概念的简单而多功能的一锅组合,以编码多样化且空间调节的降解性函数
标题:有序降解:两种大分子概念的简单而多功能的一锅组合,以编码多样化且空间调节的降解性函数
摘要:开环聚合(rop)和逐步增长聚合(sgp)这两种大分子概念的巧妙一锅组合被证明是一种简单而强大的工具,可以设计具有多样化和空间性的序列控制聚合物库.调节的降解功能.当有机催化条件从碱性切换到酸性时,Rop 和 Sgp 在室温下依次发生,并且各自允许编码特定的可降解键. Rop 控制降解功能的序列长度和位置,而互补乙烯基醚和羟基链端之间的 Sgp 能够形成缩醛键和高摩尔质量共聚物.结果是同一大分子内容易发生本体或表面侵蚀的可裂解键的合理组合.该策略用途广泛,与目前的脂肪族聚酯或聚碳酸酯相比,具有更高的化学多样性和对一级结构的控制水平,同时简单,有效,原子经济,并具有可扩展性的潜力.
DOI:10.1002/anie.202103143

海关参考信息

专利信息


专利号:US-2004018598-A1
优先权日:2000-05-30
标题 :Bio-intermediates for use in the chemical synthesis of polyketides
发明人:SANTI DANIEL; ASHLEY GARY; MYLES DAVID C
摘要:The present invention relates to compounds made by a subset of modules from one or more polyketide synthase (“PKSâ€?) genes that are used as starting material in the chemical synthesis of novel molecules, particularly naturally occurring polyketides or derivatives thereof. The biologically derived intermediates (“bio-intermediatesâ€?) generally represent particularly difficult compounds to synthesize using traditional chemical approaches due to one or more stereocenters. In one aspect of the invention, an intermediate in the synthesis of epothilone is provided that feeds into the synthetic protocol of Danishefsky and co-workers. In another aspect of the invention, intermediates in the synthesis of discodermolide are provided that feed into the synthetic protocol of Smith and co-workers. By taking advantage of the inherent stereochemical specificity of biological processes, the syntheses of key intermediates and thus the overall syntheses of compounds like epothilone and discodermolide are greaty simplified.

专利号:US-9126995-B2
优先权日:2011-11-08
标题:Method for catalytic asymmetric synthesis of optically active isoxazoline compound and optically active isoxazoline compound
发明人:TOYAMA KEN-ICHI; MORIYAMA YUJI; MATOBA KAZUTAKA; YAOSAKA MANABU; IKEDA EITATSU
权利人:NISSAN CHEMICAL IND LTD
摘要:There is provided a method for catalytic asymmetric synthesis of optically active isoxazoline compound and an optically active isoxazoline compound. A method for catalytic asymmetric synthesis of optically active isoxazoline compound of a formula (6) including reacting an α,β-unsaturated carbonyl compound of a formula (1) and a hydroxylamine in a solvent in the presence of a base by adding a chiral phase transfer catalyst. An optically active isoxazoline compound of a formula (13) that can be synthesized by the method.

专利号:US-2024024489-A1
优先权日:2020-11-20
标 题:Protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof
发明人:MULARD LAURENCE; DHARA DEBASHIS; PFISTER HELENE; PAOLETTI JULIE; PHALIPON ARMELLE; GUERREIRO-INVERNO CATHERINE
权利人:PASTEUR INSTITUT
摘要:The present invention provides zwitterionic oligosaccharides, in particular fragments of the surface polysaccharides from Shigella sonnei and Shigella sonnei conjugates comprising them. The present invention also provides protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof, the disaccharide repeating unit of Shigella sonnei being: (I)

专利号:US-10793495-B2
优先权日:2015-08-14
标 题:Synthesis of polyaryl substituted aryl compounds
发明人:BOULOS RAMIZ; FEUTRILL JOHN
权利人:BOULOS & COOPER PHARMACEUTICALS PTY LTD
摘要:A method for the synthesis of a aryl compound of Formula (1).n nU T-W—R 1 ) n    (1)

专利号:US-9085538-B2
优先权日:2010-07-26
标题:Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
发明人:CASAR ZDENKO; STERK DAMJAN; JUKIC MARKO
权利人:CASAR ZDENKO; STERK DAMJAN; JUKIC MARKO; LEK PHARMACEUTICALS
摘要:The invention relates to commercially viable process for the synthesis of key intermediates for the preparation of statins, in particular Rosuvastatin and Pitavastatin or respective pharmaceutically acceptable salts thereof. A new simple and short synthetic route for key intermediates is presented which benefits from the use of cheap and readily available starting materials, by which the conventionally most frequently used DIBAL-H as reducing agent can be avoided.

专利号:US-9676814-B2
优先权日:2013-10-01
标题:Industrial process for the synthesis of ulipristal acetate and its 4′-acetyl analogue
发明人:Mahó Sándor; SÃ?NTA CSABA; Csörgei János; Horváth János; ARANYI ANTAL; BÉNI ZOLTÃ?N
权利人:RICHTER GEDEON NYRT
摘要:The present invention relates to a new process for the synthesis of compounds of formula (I) (wherein the meaning of R is dimethylamino or acetyl group) using the compound of formula (II) (wherein the meaning of R is dimethylamino or 2-methyl-1,3-dioxolan-2-yl group) as starting material, as well as to the intermediate of the process.
常州安奈凯医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.anikare.com
企业联系电话:0519-83598696;18018249389👤
📞常州安奈凯医药科技有限公司 ⚠️参考联系方式
联系人:蒋经理
电话:0519-83598696;18018249389
手机:18018249389
传真:0519-83598696
邮箱:info@anikare.com,sales@anikare.com
通信地址: 江苏省常州市钟楼区龙城大道2239号 智谷工场
邮编: 213018
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省常州市钟楼区龙城大道2239号 智谷工场
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
邹平同丰化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.tongfeng-chem.com
企业联系电话:13505435366👤
📞邹平同丰化工有限公司 ⚠️参考联系方式
联系人:王振民
电话:13505435366
手机:13505435366
传真:0543-4969186
邮箱:zhenminwang@163.com
通信地址: 山东省邹平市车站北沿街房13号
邮编: 256200
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:山东省邹平市车站北沿街房13号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: A Closse, Et Al. Binding Studies With [参考文献]: C Moret, Et Al. Potency Ratio For The Inhibition Of 3H-Qnb And 3H-Cis-Methyldioxolane Binding Predicts Agonist Or Antagonist Activity On Muscarinic Receptors. Methods Find Exp Clin Pharmacol. 1988 Oct;10(10):619-21.
[参考文献]: H Tecle, Et Al. Synthesis And Sar Of Bulky 1-Azabicyclo[参考文献]: J B Galper, Et Al. Muscarinic Cholinergic Receptors In The Embryonic Chick Heart: Interaction Of Agonist, Receptor, And Guanine Nucleotides Studied By An Improved Assay For Direct Binding Of The Muscarinic Agonist [参考文献]: J Velazquez-Moctezuma, Et Al. Cholinergic Antagonists And Rem Sleep Generation. Brain Res. 1991 Mar 8;543(1):175-9.

合成参考文献


摘要:Bietti, M.; Dénès, F., Science of Synthesis, (2021) , 504.
摘要:Gigiena i Sanitariya. For English translation, see HYSAAV., 39(11)(94), 1974
摘要:Gigiena i Sanitariya. For English translation, see HYSAAV., 47(8)(89), 1982
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知